SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant) abx620004 from Abbexa Ltd | Biocompare.com

Supplier Images

SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant)

SDS-PAGE analysis of SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant; K417N, E484K and N501Y Mutations).
SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant)

Be the first to write a review!

Supplier Page from
Abbexa Ltd for
SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant)

Description

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Mammalian cells

Product Specs
ItemSARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant)
CompanyAbbexa Ltd
Price $334.00Supplier Page View Company Product Page
Catalog Numberabx620004
Size50 µg, 100 µg, 1 mg
FormatPrior to lyophilization: PBS, pH 7.5., Lyophilized
Conjugate/TagUnconjugated
Molecule NameSARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant)
Source/Expression SystemMammalian cells
Molecular WeightObserved MW: 35 kDa
Purity> 90% (SDS-PAGE)
SpeciesVirus
ApplicationsSDS-PAGE
StorageStore at -20°C to -80°C. Avoid repeated freeze/thaw cycles

Add to Compare List

Abbexa Ltd

Local Office

Abbexa Ltd

11152 Westheimer Rd #920

Houston, Texas 77042

United States

Phone: +1 832 327 7413
Fax: +1 832 327 7413

Email: info@labcentral.org

Company Profile

International Office

Abbexa Ltd

Abbexa Ltd

181 Cambridge Science Park

Cambridge CB4 0GJ

United Kingdom

Phone: +44 (0)1223 755950
Fax: +44 (0)1223 755951

Email: info@abbexa.com
orders@abbexa.com
support@abbexa.com
accounts@abbexa.com

Company Profile

Website: www.abbexa.com/

Be the First to Write a Review!